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Abstract
Background: There is no information concerning the genotype of Canine parvovirus (CPV) currently circulating in
Henan province, China. Therefore, the aim of the present study was to provide insights into the epidemiology and
molecular characterization of CPV circulating in Henan province from 2009 to 2014.
Results: Nineteen thousand nine hundred seven dogs from pet hospitals in the cities of Luoyang, Anyang, Jiaozuo,
Sanmenxia, Xinxiang, Zhengzhou in Henan province between 2009 and 2014 were investigated. Over the 6-year period,
1169 CPV-positive cases were identified and the morbidity of CPV infection ranged from 4.16 to 8.06 %, although
morbidity was not significant (P > 0.05) between 2009 and 2014. Factors associated with morbidity included
sampling season, dog age, breed, vaccination status, and sex. CPV co-infection with coccidium (10.00 %), canine
distemper virus (4.79 %), hookworm (2.40 %), canine coronavirus (1.11 %), roundworm (1.03 %), tapeworm (0.17 %) and
Babesia spp. (0.09 %) were observed. The new CPV-2a variant was more prevalent than the new CPV-2b variant in Henan
province. CPV 2c was not observed in this study.
Conclusions: The epidemiology of CPV infection and identification of the circulating genotypes in Henan province,
China from 2009 to 2014 determined that the new CPV-2a variant was more prevalent.
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Background
Canine parvovirus 2 (CPV-2), a member of the genus
Protoparvovirus within the family Parvoviridae (the
2014 ICTV taxonomy, website: http://ictvonline.org/
virusTaxonomy.asp), is a small, highly contagious, non-
enveloped icosahedral virus that causes acute gastro-
enteritis mainly in domestic dogs [1–5]. CPV infection is
responsible for large numbers of animal deaths world-
wide and one of the most dangerous infectious diseases
in young puppies aged 2–6 months. The infected dogs
develops acute gastroenteritis, which is characterized by
vomiting, fever, diarrhoea (from mucoid to haemorrhagic),
haemorrhagic enteritis, myocarditis and leucopoenia [6, 7].
CPV contains a single-stranded DNA genome of
approximately 5 kb, which encodes the capsid proteins
1, 2 and 3 (VP1, VP2 and VP3, respectively). VP1 and
VP2 are splice variants and mostly identical in sequence,
exclusive of a 143-amino-acid (aa) N-terminal region
unique to VP1, Whereas VP3 is derived from the cleav-
age of VP2 at the 5’-terminal region by host proteases
[8]. The full-length VP2 sequence (1755 bp) encodes the
major capsid protein, which is 584 aa in length and plays
an important role in determining viral host ranges, tissue
tropisms, and genetic and antigenic properties [9, 10].
VP2 protein had been investigated as a candidate poten-
tial vaccine antigen due to its good immunogenicity
[11]. CPV-2, first identified and described in 1978 in
both the United States and Australia, is closely related to
feline panleukopenia virus (FPV) [12]. A few years after its
emergence, the original virus type CPV-2 was replaced
worldwide by three new antigenic variants (i.e., CPV-2a,
CPV-2b and CPV-2c) based on aa substitutions (CPV-2a:
Val-555-Ile, Asp-305-Tyr, Ala-300-Gly, Ile-101-Thr and
Met-87-Leu; CPV-2b: Ile-555-Val and Asp-426-Asn;
CPV-2c: Asp-426-Glu) in the VP2 gene [12–18].
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In China, CPV infections were first described in 1982 [9].
A few years later, widespread outbreaks of canine haemor-
rhagic enteritis occurred throughout the country and CPV
infection emerged as an important zoonosis of dogs be-
cause of the high morbidity and lethality associated with
the virus [9]. Recently, different CPV genotypes were ob-
served in Heilongjiang, Jilin, Liaoning, Shandong, Hebei,
Sichuan, Shenzhen, Gansu, Beijing, and Nanjing, as well as
other areas in China [19–22]. However, no previous reports
included information about the prevalent genotype of CPV
in Henan province.
Vaccination is considered the most effective method to
control CPV infection. However, antigenic differences
may decrease the effectiveness of the vaccine based on
the original antigenic type [23]. Therefore, it is important to
elucidate the epidemiology and molecular characterization
of CPV strains currently circulating in Henan province.
Hence, in this study, we investigated the epidemiology of
CPV infection among domestic dogs in Henan province
and the molecular characterization of CPV by polymerase
chain reaction (PCR) followed by direct sequencing of iso-
lates collected from 2009 to 2014. The findings of this study
constructed a basis for the further understanding of the
evolution of CPV, will help to improve measures to prevent
and control the spread of CPV and to developt effective
vaccines against CPV infection.
Methods
Ethics statement
All animal procedures carried out in this study were ap-
proved by the Animal Care and Use Committee of
Henan University of Science and Technology. Permis-
sion to collect samples was acquired from the owner of
each animal. Samples were collected by a single skilled
veterinarian. No specific permissions were required for
collection of field samples because they were collected
from public or non-protected areas.
Samples collection
Nineteen thousand nine hundred seven dogs from pet
hospitals in the cities of Luoyang, Anyang, Jiaozuo,
Sanmenxia, Xinxiang, and Zhengzhou in Henan province
from March 2009 to December 2014 were investigated.
Among the 19,907 dogs, infections of dogs with active
vomiting, fever, diarrhoea and haemorrhagic enteritis were
detected using a CPV colloidal gold test strip (Bionote, Inc.,
Hwaseong, Gyeonggi Province, south Korea), according to
the manufacturer’s protocol. Suspected CPV-positive dogs
were confirmed by positive results of the CPV colloidal
gold test strip. Then, faecal samples from suspected
CPV-positive dogs were transferred to our laboratory
for detection of canine distemper virus (CDV) and canine
coronavirus (CCoV) using a CDV or CCoV colloidal gold
test strip (Bionote, Inc.), respectively, and for detection of
coccidium, ancylostome, roundworm, tapeworm, babe-
siosis and nematode by microscopy [24] according to the
characteristic of these parasites. Additionally, the super-
natant of faecal samples emulsified in 0.1 M phosphate-
buffered saline (pH 7.2) and centrifuged (10,000 g for
10 min at 4–8 °C) [8] was collected for detection of the
partial VP2 gene and complete VP2 gene by PCR.
Detection of CPV genome
Viral DNA was prepared by boiling the supernatant for
10 min and chilling immediately on ice as previously
described [25]. Specific primers (Table 1) for detection
of the CPV genome were designed using Primer Premier
5.0 software (Premier Biosoft International, Palto Alto,
CA, 85 USA) based on the conserved sequence of a pre-
viously published CPV genome sequence (GenBank ac-
cession no.: NC001539.1). The PCR reaction volume was
25 μl, which included 12.5 μl of PCR Master Mix (Sangon
Biotech Company, Shanghai, China), 1 μl of each primer,
1 μl of supernatant, and 9.5 μl of ultrapure water. The PCR
reaction included an initial denaturation step at 95 °C for
10 min followed by 30 cycles of 98 °C for 30 s, 55 °C for
30 s, and 72 °C for 40 s, and 72 °C for 10 min. A commer-
cial vaccine was used as a positive control and sterile water
was used as a negative control. The PCR-positive products
were sent to Sangon Biotech Company for bidirectional
single pass sequence analysis. The specificity of the se-
quences was then compared with those in the GenBank
database (http://www.ncbi.nlm.nih.gov/genbank/) using the
Basic Local Alignment Search Tool (www.ncbi.nlm.nih.gov/
BLAST). Then, all PCR-positive sequences were aligned
and three phylogenetic trees based on partial VP2 se-
quences were constructed by the Clustal W method
using the MegAlign program (DNASTAR, Inc., Madison,
WI, USA) [20].
Detection of the complete VP2 gene
Viral DNA from diverse branches was prepared as de-
scribed in this study. The primers (Table 1) for detection
of the complete VP2 gene were designed using Primer
Premier 5.0 software based on the consensus sequence
of previously published CPV genomes (GenBank acces-
sion no.: JQ268284.1). The PCR reaction volume was
25 μl, which included 12.5 μl of PCR Master Mix (Sangon
Biotech Company), 1 μl of each primer, 1 μl of supernatant,
Table 1 Primers for detection of the CPV genome and complete
VP2 gene
Name Sequence (5’→ 3’) Position (VP2) Product (bp)
CPVF GAATCTGCTACTCAGCCACCAAC 463–485 560
CPVR GTGCACTATAACCAACCTCAGC 1000–1021
VP2F AGAGACAATCTTGCACCAAT 2768–2787 1775
VP2R ATGTTAATATAATTTTCTAGGTGCT 4519–4543
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and 9.5 μl of ultrapure water. The PCR reaction included
an initial denaturation step at 95 °C for 10 min followed by
30 cycles of 98 °C for 30 s, 48 °C for 50 s, and 72 °C for
120 s, and a final extension of 72 °C for 10 min. Sterile
water was used as a negative control. The PCR positive
products were sent to Sangon Biotech Company for bidir-
ectional single pass sequence analysis. The specificity of the
sequences was then compared with those in the GenBank
database using BLASTalgorithm.
Sequence and phylogenetic analyses
The complete VP2 nucleotide sequences and aa sequences
of our samples were aligned with reference CPV sequences
from different animals and areas using MegAlign sequence
alignment software (DNASTAR 6.0) [26]. The phylogenetic
analyses based on complete VP2 nucleotide sequences
from the CPV isolates in this study and 25 reference CPV
strains were conducted by the neighbour-joining method
and a Kimura 2-parameter model using Molecular Evolu-
tionary Genetics Analysis (MEGA 5.0) software [27]. The
confidence level of branching in the phylogenetic tree was
evaluated by the bootstrap test based on 1000 resamplings.
A bootstrap value of ≥ 70 % was considered significant for
phylogenetic groupings [20]. To determine the genotype of
the CPV isolates in this study, the complete VP2 aa se-
quences were aligned with reference CPV sequences
(NCBI GenBank accession no.: M38245.1, M24003.1,
M74849.1, KT156832.1, KT156834.1 and KT156833.1)
using the DNAMAN software package (Lynnon Biosoft,
San Ramon, CA, USA) [18]. The complete VP2 DNA
sequences were also submitted to the GenBank data-
base for assignment of accession numbers.
Questionnaire survey
A questionnaire survey was created to further elucidate
the epidemiology of CPV infection among domestic dogs
between 2009 and 2014, as previously described with some
modifications [28]. The questionnaire inquired about the
followed topics: ‘CPV-positive’ (yes/no), ‘year’ (2009–2014),
‘month’ (spring, 3–5, summer, 6–8, autumn, 9–11, winter,
12–2), ‘age’ (1, 2, 3, 4, 5, 6, 6–9, 9–12, 12–36, >36 months),
‘sex’ (male or female), ‘purebred’ (yes/no), ‘vaccination’
(unvaccinated, intermittent vaccination: inoculation as
part of an unofficial immune program, complete vaccin-
ation: inoculation as part of an official immune program),
‘co-infection’ (pathogen).
Statistical analysis
Statistical analysis to assess significant differences of
morbidity was performed using SPSS version 17.0
software. A p-value <0.05 was considered statistically
significant.
Results
Morbidity of CPV infection in dogs from Henan province
One thousand one hundred seventy eight CPV-positive
cases were identified by the CPV colloidal gold test strip.
PCR analysis confirmed that 1169 (99.24 %) of these
cases were CPV-positive. Of the 1169 partial VP2 se-
quences, 33 were submitted to the NCBI Genbank data-
base under the accession numbers KF772192–KF772224.
The morbidity of CPV infection between 2009 and 2014
was 5.87 % (1169/19907). The annual morbidity rate
ranged from 4.16 to 8.06 % with the highest morbidity
recorded in 2009 and the lowest in 2012 (Fig. 1), but
morbidity was not significant (P > 0.05) between March
2009 and December 2014. In addition, we observed a
significant influence of age on morbidity (P < 0.05, Fig. 2).
Morbidity was relatively high among puppies during the
first 4 month of life with the highest rate occurring in
the third month. Afterward, the morbidity rate gradually
decreased. Seasonal morbidity ranged from 4.89 to
7.32 % with the highest during the Spring (Fig. 3). How-
ever, as a whole, differences in morbidity according to
Fig. 1 Annual distribution of morbidity of CPV infection. The morbidity rates were 51/633, 142/2291, 215/3242, 322/7746, 333/4629 and 106/1366
for 2009–2014, respectively. There was no significant difference in morbidity rates between 2009 and 2014 (P > 0.05, χ2 test)
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season was not significant (P > 0.05). There was no sig-
nificant difference in morbidity rates between male and
female dogs (643/10937, 5.88 vs. 526/8970, 5.86 %, re-
spectively, P > 0.05). The CPV-positive rate was signifi-
cantly greater among purebred dogs compared to
other dogs (1031/1169, 88.20 vs. 138/1169, 11.80 %,
respectively, P < 0.05), and was highest among unvac-
cinated dogs (680/1169, 58.17 %), although not signifi-
cantly (P = 0.069) as compared to intermittently vaccinated
dogs (463/1169, 39.61 %), but significantly (P < 0.05) as
compared to completely vaccinated dogs (26/1169, 2.22 %).
Co-infection
Over the 6-years period of this study, 230 (19.67 %) of
1169 CPV-positive cases were co-infected with other
pathogens, such as CDV, CCoV, coccidium (Isospora),
hookworm (Ancylostoma), roundworm (Toxocara), tape-
worm (Dipylidium) and Babesia spp. at rates of 4.79 %
(56/1169), 1.11 % (13/1169), 10.00 % (117/1169), 2.40 %
(28/1169), 1.03 % (12/1169), 0.17 % (2/1169) and 0.09 %
(1/1169), respectively. Additionally, of the 1169 CPV-
positive cases, 10 were co-infected with coccidium and
hookworm, five with CDV and coccidium, and four with
CCoV and coccidium.
Sequence analysis
Phylogenetic trees based on 1169 partial VP2 sequences
amplified using CPVF/CPVR primers were constructed,
which contained seven branches. One sample was selected
from each branch for amplification of the complete VP2
gene, which suggested similarity of VP2 sequences of 99 %
compared to those retrieved from the GenBank database.
The seven complete VP2 nucleotide sequences (NCBI
GenBank accession no.: KJ438798–KJ438804) and aa se-
quences were analysed using DNASTAR software, which
revealed 99.4–99.9 % homology of nucleotide sequences
and 99.1–99.8 % homology of aa sequences among the
seven isolates; 98.4–99.9 % homology of nucleotide se-
quences and 97.6–100.0 % homology of aa sequences with
CPV isolates from other provinces in China; 98.8–99.8 %
homology of nucleotide sequences and 98.1–100.0 %
homology of aa sequences with CPV isolates from other
countries; 98.0–98.3 % homology of nucleotide sequences
and 96.8–98.0 % homology of aa sequences with the FPV
isolates; <60 % homology of nucleotide and aa sequences
with porcine parvovirus; and <25 % homology of nucleo-
tide and aa sequences with goose parvovirus. Phylogenetic
tree analysis based on the seven complete VP2 nucleotide
sequences (Fig. 4) revealed that the seven isolates were
clustered to two branches. KJ438798-Henan, KJ438799-
Henan, KJ438800-Henan, KJ438802-Henan, KJ438803-
Henan and KJ438804-Henan were most closely related to
the isolate (JX120178) from Guangdong province,
southeast China, followed by the isolate (JQ268284)
from Gansu province, northwest China; KJ438801-Henan
was most closely related to the isolate (JQ743897) from
Heilongjiang province, northernmost China, followed by
the isolate (DQ903936) from Sichuan province, southwest
China.
Genotyping of CPV
Comparisons of the aa sequences among the seven iso-
lates and the six reference strains revealed that Glu426,
which is unique to strain CPV 2c, was not observed in
any strain in this study. Mutations at aa 426 (N-426-D)
and aa 297 (S-297-A) were found in one isolate (GenBank
accession no.: KJ438800), which was typed as a new CPV-
2b variant. The other isolates were typed as new CPV-2a
variants due to the aa substitutions of N426 and A297
(Table 2).
Fig. 2 Distribution of morbidity of CPV infection in relation to dog age. The incidence of morbidity at different ages was 83/836, 319/3154, 291/
2584, 145/1765, 116/1516, 75/1224, 68/1916, 41/1610, 24/2210 and 7/3092, respectively. The morbidity was relatively high in the first 4 months
with the highest recorded in month 3 (◆). After month 3, morbidity gradually decreased. However, as a whole, P-value was <0.05 for morbidity in
relation to dog age. Statistical analysis was performed using the χ2 test
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Fig. 3 Distribution of morbidity of CPV infection in relation to the season. The incidence of morbidity was 435/5946, 260/5322, 251/4465 and
223/4174 for spring, summer, autumn and winter, respectively. As a whole, the morbidity was not significant (P > 0.05). The highest morbidity (◆)
was recorded in the spring. Statistical analysis was performed using the χ2 test
Fig. 4 A Phylogenetic tree based on VP2 gene sequences of seven CPV isolates and 25 reference CPV strains by neighbor-joining method.
▲ indicates the seven CPV isolates from Henan province, China
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Discussion
This study was the first attempt to evaluate the occur-
rence of CPV infection among domestic dogs between
2009 and 2014 in Henan province, China. A diagnosis of
CPV infection based on clinical signs and the CPV col-
loidal gold test strip is rapid and often used in pet hospi-
tals in China. Of 1178 faecal samples, 1169 (99.24 %)
were CPV-positive by PCR assay, suggesting a good cor-
relation between the antigen-detection test and molecu-
lar methods, with only nine samples being recognized as
false positives. In this study, the morbidity of CPV infec-
tion was 5.87 % (1169/19907), which was lower than in
recent reports from China [20, 29]. The sample size in
this study was much larger than samples size described
previously, thus these results should represent a more ac-
curate estimate of morbidity of CPV infection. Additionally,
the χ2 test results showed that the morbidity of CPV infec-
tion fluctuated only slightly (P > 0.05) within the 6-years
period of this study (2009–2014).
The results of this study showed that morbidity in the
spring (months 3–5) and autumn (months 9–11) were
relatively higher than observed during the other seasons,
but the morbidity in Heilongjiang province differed from
that reported for other provinces [29], suggesting varia-
tions in morbidity according to the season in different
regions of China. In addition, our work demonstrated a
clear association of CPV infection with dog age (p < 0.05),
which in accordance with the results reported by Geng
et al. [29] and Cavalli et al. [30]. Although the causes of
this tendency have not yet been fully elucidated, we hy-
pothesise that the low morbidity in dogs aged < 30 days
most likely resulted from acquired maternal antibody,
while the high morbidity in dogs aged 30–120 days most
likely resulted from decreasing maternal antibody concen-
trations and stress due to weaning, and the low morbidity
in dogs aged >120 days was most likely attributable to the
development of adaptive immune responses [31, 32]. The
finding of more male dogs in this study was consistent
with those in other parts of the world, suggesting that there
also is a preference of male over female dogs in Henan
province [28]. Besides, to the best of our knowledge, this
study is the first to report that morbidity (5.88 %) in do-
mestic male dogs was similar to that (5.86 %) in domestic
female dogs. CPV infection occurs in both unvaccinated
and vaccinated dogs, in accordance with the finding of re-
cent reports in China [29, 33]. In this study, the CPV-
positive rate was highest among unvaccinated dogs,
followed by intermittently vaccinated dogs and completely
vaccinated dogs, suggesting that vaccines used in Henan
province may play an important role in prevention and
control CPV infection. These results were different from
those of previous reports from other areas of China. Our
work also indicated that the CPV-positive rate was higher
among purebred dogs as compared to mutts. This result
suggested that mutts may have greater resistance to CPV,
which should be investigated in future studies.
In this study, CPV infection was identified alongside
other pathogens in 230 (19.67 %) of 1169 CPV-positive
samples. The pathogens that accompanied CPV were
coccidium, CDV, CCoV, hookworm, roundworm, tape-
worm and Babesia spp., suggesting that these pathogens
should be considered in vaccination programs to control
Table 2 Deduced amino acid variations in VP2 in the seven CPV isolates from Henan province, China
Accession no Origin Place of amino acid sites Gene types
267 297 322 324 334 341 348 426 440
Reference
M38245 U.S. F S T Y A P S N T cpv-2
M24003 U.S. F S T Y A P S N T cpv-2a
M74849 U.S. F S T Y A P S D T cpv-2b
KT156832.1 China Y A T I A P S E T cpv-2c
KT156834.1 China Y A T I A P S N A new cpv-2a
KT156833.1 China Y A T I A P S D A new cpv-2b
This study
KJ438798 Henan Y A - I G S - N A new cpv-2a
KJ438799 Henan Y A S I - S - N A new cpv-2a
KJ438800 Henan Y A - I - - - D A new cpv-2b
KJ438801 Henan F A S I G - C N T new cpv-2a
KJ438802 Henan Y A - I - S - N A new cpv-2a
KJ438803 Henan Y A - I - S - N A new cpv-2a
KJ438804 Henan Y A - I - - - N A new cpv-2a
Identical amino acids are represented by -
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CPV outbreaks [34]. The co-infection of CPV with CDV or
CCoV in this study was in agreement with previous study
in China [29] and other countries [30, 35, 36]. Additionally,
studies in China [37] and France [38] suggested that dogs
harbouring roundworm or trichomonads were especially
susceptible to CPV infection. Also, this study is the first to
report the co-infection of CPV with coccidium, hookworm,
tapeworm or Babesia spp., and co-infection of two patho-
gens with CPV was also found in one sample.
Point mutations in the VP2 protein have been associ-
ated with the CPV types because the fragment encodes
for at least one informative aa (residue 426) of the VP2
protein, which in used to differentiate CPV2a (Asn),
CPV2b (Asp) and CPV2c (Glu) [9]. The Ser297Ala muta-
tion was used as a marker of the new CPV-2a/2b variant
[29]. CPV-2c was first identified in Jilin province, and sub-
sequently identified in Shandong province, Heilongjiang
province and Beijing [19, 29, 33]. CPV-2c was not detected
in this study, while the new CPV-2a variant is more preva-
lent than new CPV-2b variant in Henan province. In this
study, the prevalence of new CPV-2a and new CPV-2b is in
agreement with most of the reports in other provinces of
China [6, 8, 9, 20, 29, 33, 39, 40] and other countries
[26, 41–45]. The presence of the new CPV-2a and CPV-
2b variants in this study suggests that CPV-2 strains circu-
lating in Henan province also exhibit genetic variations.
VP2 encodes a viral capsid protein that is the major
structural protein of CPV-2 and is involved in the host
immune response. Therefore, a small number of muta-
tions may result in increased pathogenicity [26]. In this
study, the aa sequences from the seven VP2 gene products
revealed little variability at residues 322, 334 and 348,
which was basically consistent with reference CPV se-
quences. The aa sequences from seven VP2 gene products
revealed great variability at residues 267, 324, 341 and
440. Residue 267, located between loops 1 and 2 of the
VP2 protein, is the main component of the antigen. How-
ever, a mutation to residue 267 may not influence the anti-
genicity of CPV because it is not exposed on the capsid
surface, as was reported for strain CPV-2a from China
and Thailand and strain CPV-2b from Vietnam [45]. Resi-
due 324 is subject to positive selection and may influence
the aa sequences at residue 323, which is known to be in-
volved in host range via binding with the canine transfer-
rin receptor. A mutation at residue 323 may influence
interactions between residues in neighbouring loops of
either the same VP2 molecule or the threefold-related
VP2, thereby greatly decreasing replication in canine cells
[26]. The Y-324-I mutation in CPV-2a strains has been re-
ported in China [8, 20, 39] and other countries [43, 45].
Interestingly, variations of residue 440 (within the GH loop)
occurred. Reportedly, the high substitution rate in this re-
gion is associated with the evolution of antigenic variants in
circulating parvovirus types [46], such as strains CPV-2a
and CPV-2b from other provinces in China [9, 29]. How-
ever, the significance of a mutation at residue 341 is unclear
and warrants further investigations.
Previous reports suggested that the new CPV-2a variant
was the most prevalent in China, followed by CPV-2b and
CPV-2c, in accordance with the results of the present
study. However, it is necessary to collect more samples
form Henan province for further genotyping to improve
our understanding of the evolution of CPV in China.
Conclusions
Our results disclosed novel epidemiological information
of CPV infection in Henan province. VP2 sequences data
revealed that the new CPV-2a variant is more prevalent
than the new CPV-2b variant in Henan province. CPV-2c
was not observed in this study. The findings of this study
are expected to facilitate a better understanding of the
current status of CPV-2 infection among dogs in China.
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